COVID-19 Information

Edit Entry | Edit CV

Mark A Cervinski, PhD

Title(s)
Associate Professor of Pathology and Laboratory Medicine

Additional Titles/Positions/Affiliations
Director of Clinical Chemistry
Director of Point-Of-Care Testing
Diplomate of the American Board of Clinical Chemistry
Fellow, AACC Academy

Department(s)
Pathology and Laboratory Medicine

Education
Ph.D. Biochemistry and Molecular Biology, 2006
University of North Dakota School of Medicine and Health Sciences

Clinical Chemistry Fellowship, 2007-2009
Washington University School of Medicine

Contact Information

Department of Pathology
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756

Phone: 603 650 7114
Fax: 603 650 4845
Email: mark.a.cervinski@hitchcock.org


Professional Interests

General Clinical Chemistry
Laboratory Test Utilization Management
Real Time Patient Based Quality Control
Human Chorionic Gonadotropin
Toxicology

Courses Taught

Director of ComACC Accredited Clinical Chemistry Fellowship Program
Lecturer for the Geisel School of Medicine General Pathology Course

Biography

Mark Cervinski Ph.D DABCC, originally from Bonnyville, Alberta Canada received his Ph.D. in Biochemistry and Molecular Biology from the University of North Dakota in Grand Forks, North Dakota in 2006. Following his Ph.D. training Dr. Cervinski shifted his focus from the basic sciences to clinical chemistry and completed a Fellowship in Clinical Chemistry from Washington University in St. Louis in the summer of 2009. Mark joined the Department of Pathology and Laboratory Medicine as an Assistant Professor and as the Director of Clinical Chemistry at Dartmouth-Hitchcock Medical Center in August of 2009. Among diverse interests in clinical chemistry and laboratory medicine Dr. Cervinski is currently focused on using patient data as a supplementary quality control strategy, as well as test utilization/optimization and finding efficiencies in delivering laboratory results.

Mentoring Information

Director of the Clinical Chemistry Fellowship program at DHMC
http://www.comacc.org/training/Pages/Dartmouth_Hitchcock.html


Selected Publications

 

Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance.
Nerenz RD, Hubbard JA, Cervinski MA
Clin Lab Med. 2022 Dec;42(4):687-704. doi: 10.1016/j.cll.2022.09.018.
PMID: 36368790

An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.
Geno KA, Badea A, Lynch KL, Jannetto P, Hubbard JA, Nerenz RD, Cervinski MA
J Appl Lab Med. 2022 Oct 29;7(6):1318-1328. doi: 10.1093/jalm/jfac065.
PMID: 36036092

Reevaluating the Icterus Index Cutoff of a Jaffe Creatinine Method.
Alvarez YF, Kelliher MT, Hubbard JA, Nerenz RD, Cervinski MA
J Appl Lab Med. 2022 Sep 1;7(5):1151-1157. doi: 10.1093/jalm/jfac045.
PMID: 35899580

Wastewater-Based SARS-CoV-2 Surveillance in Northern New England.
Toledo DM, Robbins AA, Gallagher TL, Hershberger KC, Barney RE, Salmela SM, Pilcher D, Cervinski MA, Nerenz RD, Szczepiorkowski ZM, Tsongalis GJ, Lefferts JA, Martin IW, Hubbard JA
Microbiol Spectr. 2022 Apr 27;10(2):e0220721. doi: 10.1128/spectrum.02207-21. Epub 2022 Apr 12.
PMID: 35412387

Comparison of Symptoms and Antibody Response Following Administration of Moderna or Pfizer SARS-CoV-2 Vaccines.
Kelliher MT, Levy JJ, Nerenz RD, Poore B, Johnston AA, Rogers AR, Stella MEO, Snow SE, Cervinski MA, Hubbard JA
Arch Pathol Lab Med. 2022 Jun 1;146(6):677-685. doi: 10.5858/arpa.2021-0607-SA.
PMID: 35188563

Transformation of Sequential Hospital and Outpatient Laboratory Data into Between-Day Reference Change Values.
Cembrowski GS, Lyon AW, McCudden C, Qiu Y, Xu Q, Mei J, Tran DV, Sadrzadeh SMH, Cervinski MA
Clin Chem. 2022 Mar 31;68(4):595-603. doi: 10.1093/clinchem/hvab271.
PMID: 35137000

Persistently Positive Urine Amphetamines Confirmation Testing.
Goyette ERJ, Cervinski MA, Hubbard JA
Clin Chem. 2022 Feb 1;68(2):368-369. doi: 10.1093/clinchem/hvab245.
PMID: 35104855

Retrospective Evaluation of the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score.
Poore B, Hamilton R, Kelliher MT, Mahmood S, Mindiola-Romero AE, Richards R, Motanagh S, Cervinski MA, Nerenz RD
J Appl Lab Med. 2022 Jan 5;7(1):36-45. doi: 10.1093/jalm/jfab106.
PMID: 34996088

Pushing Patient-Based Quality Control Forward through Regression.
Cervinski MA
Clin Chem. 2021 Oct 1;67(10):1299-1300. doi: 10.1093/clinchem/hvab155.
PMID: 34487154

Gamma Glutamyl Transferase Activity Has Limited Utility in Assessment of Alkaline Phosphatase Elevations.
Geno KA, Poore B, Cervinski MA, Nerenz RD
J Appl Lab Med. 2021 Nov 1;6(6):1623-1627. doi: 10.1093/jalm/jfab085.
PMID: 34414431

View more publications on PubMed